Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: Unanswered questions

Norman C. Wang*, Jonathan P. Piccini, Mihai Gheorghiade

*Corresponding author for this work

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.

Original languageEnglish (US)
Pages (from-to)477-480
Number of pages4
JournalHeart Failure Reviews
Volume16
Issue number5
DOIs
StatePublished - Sep 1 2011

Keywords

  • Heart failure
  • Hospitalization
  • Implantable cardioverter-defibrillator
  • Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: Unanswered questions'. Together they form a unique fingerprint.

  • Cite this